These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16967273)

  • 41. A risk score for selective screening for gestational diabetes mellitus.
    Phaloprakarn C; Tangjitgamol S; Manusirivithaya S
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):71-5. PubMed ID: 19446948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishing diagnosis of gestational diabetes mellitus: Impact of the hyperglycemia and adverse pregnancy outcome study.
    Yogev Y; Metzger BE; Hod M
    Semin Fetal Neonatal Med; 2009 Apr; 14(2):94-100. PubMed ID: 19211315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of the Roche Accu-Chek active glucose meter to screen for gestational diabetes mellitus using fasting capillary blood.
    Dhatt GS; Agarwal MM; Othman Y; Nair SC
    Diabetes Technol Ther; 2011 Dec; 13(12):1229-33. PubMed ID: 21864017
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Relationship between tyrosine phosphorylation and protein expression of insulin receptor substrate-1 and insulin resistance in gestational diabetes mellitus].
    Qu HM; Ye YH; Peng W; Zhan Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):249-52. PubMed ID: 17631765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [For universal screening of gestational diabetes mellitus].
    Schmitz T
    Gynecol Obstet Fertil; 2008 May; 36(5):567-9. PubMed ID: 18462980
    [No Abstract]   [Full Text] [Related]  

  • 46. Gestational diabetes mellitus. Unresolved issues and future research directions.
    Okun N; Verma A; Demianczuk N
    Can Fam Physician; 1997 Jan; 43():88-93. PubMed ID: 9626427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Using the 100-g oral glucose tolerance test to predict fetal and maternal outcomes in women with gestational diabetes mellitus.
    Lin CH; Wen SF; Wu YH; Huang MJ
    Chang Gung Med J; 2009; 32(3):283-9. PubMed ID: 19527607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
    Mittermayer F; Kautzky-Willer A; Winzer C; Krzyzanowska K; Prikoszovich T; Demehri S; Wagner O; Wolzt M
    J Intern Med; 2007 Apr; 261(4):392-8. PubMed ID: 17391114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rate of abnormal results from repeated screening tests for gestational diabetes mellitus after normal initial tests.
    Boriboonhirunsarn D; Chutimongkonkul W
    J Med Assoc Thai; 2007 Jul; 90(7):1269-73. PubMed ID: 17710963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The NICHD maternal and fetal medicine unit (MFMU) network gestational diabetes mellitus trial: can we use the results as the basis for changing current screening approaches?
    Landon MB
    J Matern Fetal Neonatal Med; 2010 Mar; 23(3):210-3. PubMed ID: 20121388
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive parameters of gestational diabetes mellitus.
    Crncević-Orlić Z; Ruzić A; Miletić B; Petrović O; Zaputović L; Kehler T; Racki S; Kapović M
    Coll Antropol; 2007 Sep; 31(3):771-4. PubMed ID: 18041387
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.
    Fallucca F; Dalfrà MG; Sciullo E; Masin M; Buongiorno AM; Napoli A; Fedele D; Lapolla A
    Metabolism; 2006 Nov; 55(11):1451-6. PubMed ID: 17046546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are patients with positive screening but negative diagnostic test for gestational diabetes under risk for adverse pregnancy outcome?
    Gumus II; Turhan NO
    J Obstet Gynaecol Res; 2008 Jun; 34(3):359-63. PubMed ID: 18588612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic accuracy of fasting plasma glucose as a screening test for gestational diabetes mellitus: a systematic review and meta-analysis.
    Li M; Lan JR; Liang JL; Xiong XL
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11172-11186. PubMed ID: 33215435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?
    Akinci B; Celtik A; Yener S; Yesil S
    Diabetes Res Clin Pract; 2008 Nov; 82(2):219-25. PubMed ID: 18768235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predicting gestational diabetes: choosing the optimal early serum marker.
    Smirnakis KV; Plati A; Wolf M; Thadhani R; Ecker JL
    Am J Obstet Gynecol; 2007 Apr; 196(4):410.e1-6; discussion 410.e6-7. PubMed ID: 17403439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of gestational diabetes mellitus among pregnant women with one abnormal value of oral glucose tolerance test.
    Thanasuan S; Borriboonhirunsarn D
    J Med Assoc Thai; 2006 Aug; 89(8):1109-14. PubMed ID: 17048417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Methods of screening of gestational diabetes between 24 and 28 weeks' gestation].
    Virally M; Laloi-Michelin M
    J Gynecol Obstet Biol Reprod (Paris); 2010 Dec; 39(8 Suppl 2):S220-38. PubMed ID: 21185473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. "Abnormal" fasting plasma glucose during pregnancy.
    Seshiah V; Balaji V; Panneerselvam A; Balaji MS
    Diabetes Care; 2008 Dec; 31(12):e92. PubMed ID: 19033414
    [No Abstract]   [Full Text] [Related]  

  • 60. Screening for gestational diabetes mellitus.
    Greene MF
    N Engl J Med; 1997 Nov; 337(22):1625-6. PubMed ID: 9371862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.